George Ν. Dalekos

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 541 citations

Medicine, Oncology, Hepatology +13

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 539 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

Tobias J. Weismüller, Palak Trivedi, Annika Bergquist et al. · Gastroenterology · 2017 · 523 citations · Full text

Medicine, Internal Medicine, Pathology +13

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

Heiner Wedemeyer, Cihan Yurdaydın, George Ν. Dalekos et al. · New England Journal of Medicine · 2011 · 474 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Rong Fan, George Papatheodoridis, Jian Sun et al. · Journal of Hepatology · 2020 · 349 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16